Medicus Pharma Ltd. completed sales of 4,471,038 common shares to Yorkville under the Standby Equity Purchase Agreement dated February 10, 2025, for aggregate consideration of approximately $3,846,910. Part of the net proceeds were used to prepay a portion of an outstanding debenture with Yorkville, with shares issued under Section 4(a)(2) exemption.
Key takeaways
Sold 4,471,038 Common Shares to YA II PN, Ltd. (Yorkville) for $3,846,910 total
Largest sales on March 5, 2026: 700,000 shares for $988,890 and 1,360,000 shares for $1,047,336
Sales occurred from December 19, 2025 to March 6, 2026 under SEPA dated February 10, 2025
Net proceeds partially used to prepay Yorkville debenture per 8-K dated September 18, 2025
Shares issued exempt under Section 4(a)(2); Yorkville may resell via effective registration statement